Increased dendritic MAP2 expression in the hippocampus in schizophrenia

Area of Science:

• Neuroscience
• Cell Biology
• Psychiatry

Background:

• Microtubule-associated proteins (MAPs) are crucial for neuronal structure.
• Alterations in MAPs have been implicated in schizophrenia pathogenesis.
• MAP2 is a key protein in dendritic development and maintenance.

Purpose of the Study:

• To quantitatively assess differences in MAP2 immunoreactive dendritic length in hippocampal subregions of individuals with schizophrenia compared to controls.
• To investigate the expression of total MAP2 (MAP2-T) and a non-phosphorylated form (MAP2-NP).

Main Methods:

• Stereological length estimation technique using Bouffon's Needle principle.
• Image analysis software applied to hippocampal tissue from 12 schizophrenic and 12 control subjects.
• Antibodies targeting MAP2-T and MAP2-NP were used to measure dendritic arborization.

Main Results:

• Significant elevations in MAP2-NP immunoreactive dendritic length were found in CA3, CA2, CA1, and subicular regions of schizophrenic subjects.
• MAP2-T immunoreactive dendritic length was also elevated in CA1, CA4, and subicular regions.
• These increases were observed after controlling for age and post-mortem delay.

Conclusions:

• The study provides quantitative evidence of increased MAP2 immunoreactive dendritic arborization in the hippocampus in schizophrenia.
• Findings suggest potential alterations in dendritic structure or MAP2 levels within hippocampal pyramidal neurons in schizophrenia.
• These results contribute to understanding synaptodendritic abnormalities in schizophrenia.